A detailed history of Arrow Mark Colorado Holdings LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 541,124 shares of RLAY stock, worth $2.38 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
541,124
Previous 541,124 -0.0%
Holding current value
$2.38 Million
Previous $3.53 Million 8.59%
% of portfolio
0.05%
Previous 0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.9 - $8.02 $20.4 Million - $27.8 Million
-3,464,046 Reduced 86.49%
541,124 $3.53 Million
Q1 2024

May 15, 2024

BUY
$7.5 - $12.07 $681,930 - $1.1 Million
90,924 Added 2.32%
4,005,170 $33.2 Million
Q4 2023

Feb 14, 2024

BUY
$6.01 - $11.48 $2.98 Million - $5.69 Million
495,577 Added 14.5%
3,914,246 $43.1 Million
Q2 2023

Aug 14, 2023

BUY
$9.99 - $18.27 $7.48 Million - $13.7 Million
748,472 Added 28.03%
3,418,669 $42.9 Million
Q1 2023

May 15, 2023

SELL
$15.0 - $22.76 $247,710 - $375,858
-16,514 Reduced 0.61%
2,670,197 $44 Million
Q4 2022

Feb 14, 2023

BUY
$14.16 - $24.02 $2.47 Million - $4.19 Million
174,243 Added 6.94%
2,686,711 $40.1 Million
Q3 2022

Nov 14, 2022

SELL
$18.07 - $31.37 $5.93 Million - $10.3 Million
-328,205 Reduced 11.55%
2,512,468 $56.2 Million
Q2 2022

Aug 15, 2022

BUY
$13.31 - $34.88 $10.9 Million - $28.4 Million
815,559 Added 40.27%
2,840,673 $47.6 Million
Q1 2022

May 16, 2022

SELL
$20.26 - $32.36 $166,334 - $265,675
-8,210 Reduced 0.4%
2,025,114 $60.6 Million
Q4 2021

Feb 14, 2022

BUY
$26.0 - $37.03 $41.4 Million - $58.9 Million
1,590,591 Added 359.27%
2,033,324 $62.4 Million
Q3 2021

Nov 15, 2021

BUY
$29.75 - $37.99 $2.1 Million - $2.68 Million
70,538 Added 18.95%
442,733 $14 Million
Q2 2021

Aug 16, 2021

BUY
$27.5 - $38.19 $900,872 - $1.25 Million
32,759 Added 9.65%
372,195 $13.6 Million
Q1 2021

May 17, 2021

SELL
$32.52 - $61.53 $27,349 - $51,746
-841 Reduced 0.25%
339,436 $11.7 Million
Q4 2020

Feb 16, 2021

SELL
$35.51 - $54.03 $166,080 - $252,698
-4,677 Reduced 1.36%
340,277 $14.1 Million
Q3 2020

Nov 16, 2020

BUY
$32.81 - $45.1 $11.3 Million - $15.6 Million
344,954 New
344,954 $14.7 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $528M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.